ERBB2 and breast cancer: The capability of mRNA ISH to specifically discriminate between the constitutively expressed d16HER2 and WTHER2 isoforms was also confirmed by parallel qPCR testing of HER2-positive cell lines derived from both BC and GC/OGC.